InMed Pharmaceuticals Inc

Company Profile

• Business description

  InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The Company’s operations consist of two operating and reportable segments, the InMed Pharma segment and the BayMedica Commercial segment. The InMed Pharma segment is largely organized around the research and development of small molecule pharmaceuticals drug candidates and the BayMedica Commercial segment is largely organized around manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer’s disease.

• Contact

  885 West Georgia Street
  Suite 1445
  VancouverBCV6C 3E8
  CAN

  T: +1 604 669-7207

  E: [email protected]

  https://www.inmedpharma.com

• Sector

  Healthcare

  Stock type

  Defensive

• Industry

  Drug Manufacturers - Specialty & Generic

  Fiscal Year End

  30 June 2026

  Employees

  13